Insider trades › Roger Jeffs
Roger Jeffs
A corporate insider: an officer, director or owner of more than 10% of a company. Insiders report their trades to the SEC on Form 4The form insiders use to report each purchase or sale of their company's stock. It is due within two business days of the trade. · Last filing Jul 14, 2026
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, list Roger Jeffs's open-market buys and sells across companies in the last two years, with the Form 4 links.
Using 13F.ai, how did the stocks Roger Jeffs bought perform after the purchase compared with the S&P 500?
Using 13F.ai, are other insiders at the same companies buying or selling at the same time as Roger Jeffs?
Connect your AI · Plans and the 7-day free trial (card required)
Buying and selling by quarter
Dollars bought and sold on the open market over the last two years.
Bought Sold
By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.
Roles
The companies where this person reports as an insider, and their position at each, most recent first.
Latest open-market trades
Purchases and sales at every company, most recent filing first.
| How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss. | Filing | ||||||
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | LQDA Liquidia Corporation | Sale | 2,505 | $71.39 | $178.8K | -20.1% | Form 4 ↗ |
| Jul 13, 2026 | LQDA Liquidia Corporation | Sale | 32,744 | $71.52 | $2.3M | -20.1% | Form 4 ↗ |
| Jun 11, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 286 | $249.12 | $71.2K | -46.4% | Form 4 ↗ |
| Jun 10, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 286 | $246.18 | $70.4K | -46.5% | Form 4 ↗ |
| May 27, 2026 | LQDA Liquidia Corporation | Sale | 6,428 | $62.18 | $399.7K | -8.0% | Form 4 ↗ |
| May 26, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $60.38 | $1.5M | -5.0% | Form 4 ↗ |
| May 22, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $61.52 | $1.5M | -7.0% | Form 4 ↗ |
| May 21, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $61.13 | $1.5M | -8.9% | Form 4 ↗ |
| May 20, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $61.30 | $1.5M | -8.8% | Form 4 ↗ |
| May 19, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $58.65 | $1.5M | -7.1% | Form 4 ↗ |
| May 18, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $56.77 | $1.4M | -1.4% | Form 4 ↗ |
| May 15, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $57.04 | $1.4M | -1.2% | Form 4 ↗ |
| May 14, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $58.62 | $1.5M | -4.0% | Form 4 ↗ |
| May 13, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $56.29 | $1.4M | -1.9% | Form 4 ↗ |
| May 12, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $54.04 | $1.4M | -0.8% | Form 4 ↗ |
| May 11, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $41.50 | $1.0M | +6.0% | Form 4 ↗ |
| May 8, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $42.14 | $1.1M | +33.5% | Form 4 ↗ |
| May 7, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $42.09 | $1.1M | +32.7% | Form 4 ↗ |
| May 6, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $40.78 | $1.0M | +33.4% | Form 4 ↗ |
| May 5, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $40.10 | $1.0M | +38.8% | Form 4 ↗ |
| Apr 17, 2026 | LQDA Liquidia Corporation | Sale | 18,839 | $40.60 | $764.9K | +39.2% | Form 4 ↗ |
| Apr 16, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $40.31 | $1.0M | +31.2% | Form 4 ↗ |
| Apr 15, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $40.14 | $1.0M | +35.3% | Form 4 ↗ |
| Apr 14, 2026 | LQDA Liquidia Corporation | Sale | 3,300 | $40.00 | $132.0K | +39.7% | Form 4 ↗ |
| Apr 13, 2026 | LQDA Liquidia Corporation | Sale | 32,744 | $38.37 | $1.3M | +37.8% | Form 4 ↗ |
| Apr 10, 2026 | LQDA Liquidia Corporation | Sale | 21,433 | $40.12 | $859.9K | +37.9% | Form 4 ↗ |
| Apr 9, 2026 | LQDA Liquidia Corporation | Sale | 25,000 | $40.12 | $1.0M | +31.4% | Form 4 ↗ |
| Jan 12, 2026 | LQDA Liquidia Corporation | Sale | 66,610 | $37.43 | $2.5M | +48.3% | Form 4 ↗ |
| Oct 13, 2025 | LQDA Liquidia Corporation | Sale | 20,261 | $23.41 | $474.3K | +127.7% | Form 4 ↗ |
| Sep 2, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 13,464 | $123.68 | $1.7M | -3.1% | Form 4 ↗ |
| Aug 29, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 20,000 | $121.27 | $2.4M | -0.1% | Form 4 ↗ |
| Aug 28, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 20,000 | $121.60 | $2.4M | +0.1% | Form 4 ↗ |
| Aug 27, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 20,000 | $122.30 | $2.4M | -0.4% | Form 4 ↗ |
| Aug 26, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 20,000 | $120.03 | $2.4M | +0.0% | Form 4 ↗ |
| Aug 22, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 16,694 | $120.08 | $2.0M | +2.7% | Form 4 ↗ |
| Jul 14, 2025 | LQDA Liquidia Corporation | Sale | 20,252 | $14.28 | $289.2K | +275.7% | Form 4 ↗ |
| Jul 14, 2025 | LQDA Liquidia Corporation | Sale | 20,252 | $14.28 | $289.2K | +275.7% | Form 4 ↗ |
| Jun 4, 2025 | LQDA Liquidia Corporation | Sale | 30,610 | $16.97 | $519.5K | +199.6% | Form 4 ↗ |
| Apr 14, 2025 | LQDA Liquidia Corporation | Sale | 14,130 | $13.57 | $191.7K | +275.2% | Form 4 ↗ |
| Jan 14, 2025 | LQDA Liquidia Corporation | Sale | 22,343 | $11.78 | $263.2K | +375.8% | Form 4 ↗ |
| Oct 14, 2024 | LQDA Liquidia Corporation | Sale | 8,053 | $11.11 | $89.5K | +386.5% | Form 4 ↗ |
Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.
When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.